Fezolinetant in the treatment of vasomotor symptoms associated with menopause
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2021.1893305
Abstract: ABSTRACT Introduction: Although international clinical practice guidelines recognize a continued role for menopausal hormone therapy (HT), particularly for symptomatic women read more here.
Keywords: clinical development; menopause; fezolinetant treatment; vasomotor symptoms ... See more keywords